Shanghai Pharmaceuticals Updates Interim Dividend and Tax Details for H ShareholdersTip Ranks·Sep 3 at 09:38 AM02607+0.26%601607+0.12%
Shanghai Pharma, SIIC-controlled unit, steps up innovation push via national immunotherapy lab partnershipPUBT·Aug 24 at 12:56 AM02607+0.26%601607+0.12%
Shanghai Industrial Investment president Zhang Qian visits Shanghai Pharmaceuticals Central Research Institute in Beijing for R&D reviewPUBT·Aug 13 at 01:37 AM02607+0.26%601607+0.12%
Shanghai Pharmaceuticals Finalizes Participation in Shanghai Biomedical Phase II FundTip Ranks·Jul 24 at 12:08 PM02607+0.26%601607+0.12%
The 2026 Hong Kong Reality Check: Who's Actually Delivering?Global Report·Jul 22 at 09:17 AM09923-0.81%03931-3.10%
Shanghai Pharmaceuticals Joins RMB Biomedical Fund in Connected TransactionTip Ranks·Jul 17 at 12:39 PM601607+0.12%02607+0.26%
Shanghai Industrial chair visits Shanghai Pharma’s herbal medicine unit for reform reviewPUBT·Jul 15 at 01:01 AM601607+0.12%02607+0.26%
Shanghai Pharmaceuticals Revises Vote Data on 2025 Profit Distribution PlanTip Ranks·Jul 8 at 12:07 PM02607+0.26%601607+0.12%
Biotech Breakthroughs and Data Center Hardware Pace Resilient Pockets in HK EquitiesGlobal Report·Jul 7 at 10:38 AM01513+0.77%01833-1.97%
Shanghai Pharmaceuticals AGM Secures Strong Shareholder Backing and Governance StabilityTip Ranks·Jun 25 at 01:13 PM601607+0.12%02607+0.26%
G Sachs Raises SH PHARMA TP to HKD10.63, Maintains Sell RatingAASTOCKS News·May 5 at 02:38 AM02607+0.26%601607+0.12%
SH PHARMA 1Q26 Attributable Net Profit Up 6.35% YoYAASTOCKS News·Apr 29 at 09:18 AM601607+0.12%02607+0.26%
M Stanley Cuts Shanghai Pharmaceuticals Holding TP to HKD15.8, Rating OverweightAASTOCKS News·Apr 24 at 03:18 AM601607+0.12%02607+0.26%
Bank of America Securities raises Shanghai Pharma's target price to 14 yuan, reiterates "Buy"AASTOCKS·Apr 8 at 07:18 AM159316-0.17%159102+0.48%
